Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial (Q45418240)
Jump to navigation
Jump to search
scientific article published on 31 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial |
scientific article published on 31 July 2012 |
Statements
1 reference
Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial (English)
1 reference
Cees G M Kallenberg
1 reference
Rodney P E Pollard
1 reference
Wayel H Abdulahad
1 reference
Arjan Vissink
1 reference
Nishath Hamza
1 reference
Johannes G M Burgerhof
1 reference
Jiska M Meijer
1 reference
Annie Visser
1 reference
Minke G Huitema
1 reference
Fred K L Spijkervet
1 reference
Hendrika Bootsma
1 reference
Frans G M Kroese
1 reference
31 July 2012
1 reference
1 reference
72
1 reference
1
1 reference
146-148
1 reference
Identifiers
1 reference
1 reference